SCHEMBL7797477

SCHEMBL7797477

N[C@H](CC(=O)c1ccc(F)cc1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMO O15229 3/20 0.58
PTPN1 P18031 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
ATM Q13315 1/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
GRIK1 P39086 1/20 0.48
GRIK2 Q13002 1/20 0.48
KIF11 P52732 1/20 0.45
KDM4E B2RXH2 1/20 0.45
HIF1A Q16665 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
HTR7 P34969 1/20 0.44
PLOD2 O00469 1/20 0.44
TSHR P16473 1/20 0.44
HSD11B1 P28845 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7797479 1.00 KMO (0.58) KMOPTPN1MEN1KMT2AATM
Hydrochloric Acid SCHEMBL27448087 0.98 KMO (0.59) KMOPTPN1MEN1KMT2AATM
Hydrochloric Acid SCHEMBL27448086 0.98 KMO (0.59) KMOPTPN1MEN1KMT2AATM
SCHEMBL27125732 0.87 MEN1 (0.47) KMOPTPN1MEN1KMT2AATM
SCHEMBL9064982 0.83 KMO (0.60) KMOKDM4EHIF1ATDP1TSHR
SCHEMBL5281538 0.83 KMO (0.60) KMOPTPN1NPC1RAB9AKIF11
SCHEMBL2791083 0.82 TSHR (0.64) KMOPTPN1MEN1KMT2ANPC1
SCHEMBL7799557 0.82 TSHR (0.64) KMOPTPN1MEN1KMT2ANPC1
SCHEMBL2860324 0.82 TSHR (0.64) KMOPTPN1MEN1KMT2ANPC1
SCHEMBL7801999 0.81 KMO (0.68) KMOMEN1KMT2AGRIK1GRIK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES VARASI MARIO (IT) 2001-07-19 US disclosed
EP-0662948-B1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN SPA (IT) 1998-10-07 EP disclosed
EP-0662948-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN S.p.A. (IT) 1995-07-19 EP disclosed
WO-1995003271-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA S.P.A. (IT) 1995-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES KYNU, KMO, ABAT KMO 2/4885PTPN1 3191/4885MEN1 4851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.